Carboplatin response in ovarian cancer spheroids
Cell-based study · OV1946 and TOV21G ovarian cancer cell-line spheroids; representative models from a six-line panel. [1]
Viability responses differed by model. The fitted IC50 was 75.32 µM in OV1946 and 280.8 µM in TOV21G. These are endpoint estimates after exposure and recovery, rather than fixed treatment doses. The disputed OV4453 spheroid IC50 is excluded.
| Endpoint | Reported result | Reference |
|---|---|---|
| Viable-cell proportion after carboplatin exposure and recovery | IC50 75.32 µM | [1] |
| Viable-cell proportion after carboplatin exposure and recovery | IC50 280.8 µM | [1] |
Literature-Reported Treatment Conditions
- Treatment concentration
- OV1946: 12, 60 and 300 µM; TOV21G: 60, 180 and 540 µM (final in-well concentrations).
- Exposure duration
- 24 h treatment followed by 24 h recovery.
- Method
- Carboplatin added to preformed spheroids; complete OSE medium added to untreated controls. Ten spheroids pooled per replicate; two replicates per condition.
- Co-treatment
- Carboplatin alone.
- Reported limits
- No additional drug solvent is specified for spheroid treatment in the retrieved methods. IC50 uncertainty intervals are not supplied in Figure 3.
Methods and source locations
Compound reported in the paper: Carboplatin; Compound label in the paper: Carboplatin
Reported experimental carboplatin responses; no supplier-lot validation or clinical dose extrapolation.
Figure 3C–D; Methods, 3D spheroid formation, Carboplatin treatment/3D spheroid model, Flow cytometry analysis, Statistical analyses
Viable-cell proportion after carboplatin exposure and recovery: LIVE-DEAD Fixable Aqua staining and flow cytometry; normalized dose–response regression. Three independent experiments, two replicates per condition; curves show mean ± SEM. — Figure 3C–D; Results, Carboplatin response of 3D EOC spheroids; Methods, Flow cytometry analysis of 3D spheroids
Viable-cell proportion after carboplatin exposure and recovery: Same experiment and assay design as OV1946. Three independent experiments, two replicates per condition; curves show mean ± SEM. — Figure 3C–D; Methods, Flow cytometry analysis of 3D spheroids